Publications by authors named "M Patteson"
Article Synopsis
- She was a trailblazer in veterinary radiology, making significant contributions to the field.
- Known for her passion for teaching, she inspired many students and professionals alike.
- Her impact extended beyond her work as she served as a role model for aspiring veterinarians.
Article Synopsis
- The EPIC study looked at how to help dogs with a heart issue called myxomatous mitral valve disease (MMVD) by using a medicine called pimobendan, but not all vets can do special heart tests called echocardiograms.
- Researchers trained regular vets with no heart testing experience to use echocardiograms to check if dogs matched the criteria for treatment.
- After the training, these vets were pretty good at finding out which dogs needed help, agreeing with heart specialists in most cases, meaning the training was successful!
Objectives: To identify the predictive value on time to onset of heart failure (HF) or cardiac death of clinical, radiographic, and echocardiographic variables, as well as cardiac biomarkers N-terminal pro brain natriuretic peptide (NT-proBNP) and cardiac troponin I in dogs with preclinical myxomatous mitral valve disease (MMVD).
Animals: One hundred sixty-eight dogs with preclinical MMVD and left atrium to aortic root ratio ≥1.6 (LA:Ao) and normalized left ventricular end-diastolic diameter ≥1.
Article Synopsis
- The EPIC study monitored dogs with myxomatous mitral valve disease (MMVD) to observe how they develop congestive heart failure (CHF).
- It compared clinical and radiographic changes in dogs that developed CHF against those that did not, analyzing factors like heart rate and respiratory rate.
- Key findings showed that dogs approaching CHF had significant increases in respiratory rates and heart rates, along with decreases in body weight and temperature, highlighting respiratory rates as crucial indicators of CHF onset.
Introduction: Efficacy of renin-angiotensin-aldosterone system (RAAS) blockade using angiotensin-converting enzyme inhibitors (ACEi) in dogs with preclinical myxomatous mitral valve disease (MMVD) is controversial.
Hypothesis: Administration of spironolactone (2-4 mg q 24 h) and benazepril (0.25-0.